載入...
Alpha-1 antitrypsin for cystic fibrosis complicated by severe cytokinemic COVID-19
BACKGROUND: The clinical course of severe COVID-19 in cystic fibrosis (CF) is incompletely understood. We describe the use of alpha-1 antitrypsin (AAT) as a salvage therapy in a critically unwell patient with CF (PWCF) who developed COVID-19 while awaiting lung transplantation. METHODS: IV AAT was a...
Na minha lista:
| 發表在: | J Cyst Fibros |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7678455/ https://ncbi.nlm.nih.gov/pubmed/33288475 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcf.2020.11.012 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|